Page last updated: 2024-08-25

corilagin and Cirrhosis, Liver

corilagin has been researched along with Cirrhosis, Liver in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, Q; Chen, Y; Huang, S; Kong, W; Kuang, S; Lv, Z; Wang, F; Wang, Y; Wu, C; Xie, S; Zeng, T; Zheng, R; Zhou, C1
Bag, P; Das, S; Dave, P; Kumar, A; Mullick, R; Nandhitha, M; Reddy, BU; Roy, CL; Sharma, G; Shukla, A; Srinivasan, N; Srinivasan, P; Sudha, G; Tandon, H1
Chen, YF; Li, QQ; Ma, Q; Shang, ZZ; Wang, Y; Xue, J; Yang, F; Zhang, J; Zhang, SL; Zhao, L1
Dong, JH; Guo, YJ; Li, G; Li, HR; Li, M; Luo, T; Wang, H; Wu, F; Zhang, SL; Zhao, L1
Chen, YF; Du, P; Li, G; Li, QQ; Ma, Q; Shang, ZZ; Wang, Y; Zhang, J; Zhao, L; Zhu, ZD1

Other Studies

5 other study(ies) available for corilagin and Cirrhosis, Liver

ArticleYear
Corilagin alleviates liver fibrosis in zebrafish and mice by repressing IDO1-mediated M2 macrophage repolarization.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 119

    Topics: Animals; Liver Cirrhosis; Liver Neoplasms; Macrophages; Mice; Tumor Microenvironment; Zebrafish

2023
A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage.
    Antiviral research, 2018, Volume: 150

    Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cells, Cultured; Disease Models, Animal; Gene Expression; Genes, Reporter; Glucosides; Hepacivirus; Hepatitis C; Humans; Hydrolyzable Tannins; Liver; Liver Cirrhosis; Mice; NADPH Oxidase 4; Oxidative Stress; Plant Extracts; Rats; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta; Viral Nonstructural Proteins; Virus Replication

2018
Effect of Corilagin on the miR-21/smad7/ERK signaling pathway in a schistosomiasis-induced hepatic fibrosis mouse model.
    Parasitology international, 2016, Volume: 65, Issue:4

    Topics: Animals; Connective Tissue Growth Factor; Disease Models, Animal; Female; Glucosides; Humans; Hydrolyzable Tannins; Liver Cirrhosis; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; MicroRNAs; Protein Serine-Threonine Kinases; Quality of Life; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Schistosoma japonicum; Schistosomiasis japonica; Smad7 Protein

2016
Corilagin ameliorates schistosomiasis hepatic fibrosis through regulating IL-13 associated signal pathway in vitro and in vivo.
    Parasitology, 2016, Volume: 143, Issue:12

    Topics: Animals; Blotting, Western; Cell Line; Collagen; Disease Models, Animal; Gastrointestinal Agents; Gene Expression Profiling; Glucosides; Histocytochemistry; Hydrolyzable Tannins; Immunohistochemistry; Interleukin-13; Interleukin-13 Receptor alpha1 Subunit; Janus Kinase 1; Liver; Liver Cirrhosis; Mice, Inbred BALB C; Microscopy; Models, Biological; Rats; Real-Time Polymerase Chain Reaction; Schistosomiasis; Signal Transduction; Treatment Outcome

2016
Mechanism of Corilagin interference with IL-13/STAT6 signaling pathways in hepatic alternative activation macrophages in schistosomiasis-induced liver fibrosis in mouse model.
    European journal of pharmacology, 2016, Dec-15, Volume: 793

    Topics: Animals; Disease Models, Animal; Gene Expression Regulation; Glucosides; Hydrolyzable Tannins; Interleukin-13; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Liver; Liver Cirrhosis; Macrophage Activation; Macrophages; Male; Mice; Schistosomiasis; Signal Transduction; STAT6 Transcription Factor

2016